Spex Capital
Venture capital
UncertainLast verified 7 Nov 2026
London-based venture capital firm investing in early-stage digital health and medtech startups, offering initial tickets of €500k to €2m with follow-on capacity and clinical validation support.
0 deals in the last 24 months. Taken from its own website.
Key facts
- Stages
- Seed, Series A
- Sectors
- Healthtech, Medtech
- Ticket
- €500K–€2M
- Eligible countries
- Not stated
- Provider based in
- United Kingdom
- Timing
- Rolling applications
- Focus
- digital healthcare; medical technology; telemedicine; medical devices; diagnostics; digital therapeutics
- How to apply
- Apply route unknown
Recent deals
No deals in our data for the last 24 months.
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Spex Capital is a specialised venture capital firm focused exclusively on early-stage digital healthcare and medical technology investments.
https://eutechfuture.com/venture-capital/spex-capital-healthtech-vc-fund - Sectors
Invests exclusively in digital health and medical technology solutions, including telemedicine, software, medical devices, diagnostics, and digital…
https://eutechfuture.com/venture-capital/spex-capital-healthtech-vc-fund - Ticket
Typically invests between €500,000 and €2 million initially
https://eutechfuture.com/venture-capital/spex-capital-healthtech-vc-fund - Ticket
Typically invests between €500,000 and €2 million initially
https://eutechfuture.com/venture-capital/spex-capital-healthtech-vc-fund
Status history
- 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at Spex Capital? Claim this profile to confirm what you invest in.